These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 19123460

  • 1. Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases.
    Bussone G, Ribeiro E, Dechartres A, Viallard JF, Bonnotte B, Fain O, Godeau B, Michel M.
    Am J Hematol; 2009 Mar; 84(3):153-7. PubMed ID: 19123460
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia.
    Maung SW, Leahy M, O'Leary HM, Khan I, Cahill MR, Gilligan O, Murphy P, McPherson S, Jackson F, Ryan M, Hennessy B, McHugh J, Goodyer M, Bacon L, O'Gorman P, Nee A, O'Dwyer M, Enright H, Saunders J, O'Keeffe D.
    Br J Haematol; 2013 Oct; 163(1):118-22. PubMed ID: 23909468
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults.
    Provan D, Butler T, Evangelista ML, Amadori S, Newland AC, Stasi R.
    Haematologica; 2007 Dec; 92(12):1695-8. PubMed ID: 18055995
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Rituximab instead of splenectomy in 4 children with chronic or refractory autoimmune haemolytic anaemia].
    van Daalen ST, van Dijken PJ, Tamminga RY, Brons PP.
    Ned Tijdschr Geneeskd; 2005 Oct 15; 149(42):2350-4. PubMed ID: 16261716
    [Abstract] [Full Text] [Related]

  • 10. Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology.
    Dungarwalla M, Marsh JC, Tooze JA, Lucas G, Ouwehand W, Pettengell R, Dearden CE, Gordon Smith EC, Elebute MO.
    Ann Hematol; 2007 Mar 15; 86(3):191-7. PubMed ID: 17123083
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S, Benseler SM, Kirby-Allen M, Silverman ED.
    Pediatrics; 2009 Jan 15; 123(1):e159-63. PubMed ID: 19074962
    [Abstract] [Full Text] [Related]

  • 15. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
    Gentile M, Lucia E, Iorio C, Vigna E, Mazzone C, Morelli R, Bisconte MG, Gentile C, Morabito F.
    Cancer Chemother Pharmacol; 2008 Sep 15; 62(4):741-3. PubMed ID: 18064461
    [Abstract] [Full Text] [Related]

  • 16. Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab.
    Ramanathan S, Koutts J, Hertzberg MS.
    Am J Hematol; 2005 Feb 15; 78(2):123-6. PubMed ID: 15682420
    [Abstract] [Full Text] [Related]

  • 17. Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single-center experience with 60 patients.
    Roumier M, Loustau V, Guillaud C, Languille L, Mahevas M, Khellaf M, Limal N, Noizat-Pirenne F, Godeau B, Michel M.
    Am J Hematol; 2014 Sep 15; 89(9):E150-5. PubMed ID: 24847759
    [Abstract] [Full Text] [Related]

  • 18. Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency.
    Kim JJ, Thrasher AJ, Jones AM, Davies EG, Cale CM.
    Br J Haematol; 2007 Jul 15; 138(1):94-6. PubMed ID: 17498197
    [Abstract] [Full Text] [Related]

  • 19. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.
    El-Hallak M, Binstadt BA, Leichtner AM, Bennett CM, Neufeld EJ, Fuhlbrigge RC, Zurakowski D, Sundel RP.
    J Pediatr; 2007 Apr 15; 150(4):376-82. PubMed ID: 17382113
    [Abstract] [Full Text] [Related]

  • 20. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
    D'Arena G, Laurenti L, Capalbo S, D'Arco AM, De Filippi R, Marcacci G, Di Renzo N, Storti S, Califano C, Vigliotti ML, Tarnani M, Ferrara F, Pinto A.
    Am J Hematol; 2006 Aug 15; 81(8):598-602. PubMed ID: 16823816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.